Does hepatitis C increase the accumulation of advanced glycation end products in haemodialysis patients?

Arsov, Stefan; Graaff, Reindert; Morariu, Aurora M; van Oeveren, Wim; Smit, Andries J; Bushletikj, Irena; Trajcheska, Lada; Selim, Gjulshen; Dzekova Vidimliski, Pavlina; Stegmayr, Bernd; Shikole, Aleksandar; Rakhorst, Gerhard

doi:10.1093/ndt/gfp564

Does hepatitis C increase the accumulation of advanced glycation end products in haemodialysis patients?

Journal

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Date Issued

2010-03

Author(s)

Arsov, Stefan

Graaff, Reindert

Morariu, Aurora M

van Oeveren, Wim

Smit, Andries J

Bushletikj, Irena

Stegmayr, Bernd

Rakhorst, Gerhard

DOI

10.1093/ndt/gfp564

Abstract

Hepatitis C may cause increased levels of oxidative stress that contribute to accumulation of advanced glycation end products (AGEs), which increase the risk of cardiovascular disease (CVD). The aim of this study was to determine the influence of hepatitis C on AGE accumulation in haemodialysis patients.